References
Birmaher, B., Brent, D. A., Chiappetta, L., Bridge, J., Monga, S., & Baugher, M. (1999). Psychometric
properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): A replication study. Journal of the American Academy of Child and Adolescent Psychiatry, 38(10), 1230–1236. https://doi.org/10.1097/00004583-199910000-00011
Gregory, K. D., Chelmow, D., Nelson, H. D., Van Niel, M. S., Conry, J. A., Garcia, F., Kendig, S. M.,
O’Reilly, N., Qaseem, A., Ramos, D., Salganicoff, A., Son, S., Wood, J. K., & Zahn, C. (2020). Screening for Anxiety in Adolescent and Adult Women: A Recommendation From the Women’s Preventive Services Initiative. Annals of Internal Medicine, 173(1), 48–56. https://doi.org/10.7326/M20-0580
Hussain, F. S., Dobson, E. T., & Strawn, J. R. (2016). Pharmacologic Treatment of Pediatric Anxiety
Disorders. Current Treatment Options in Psychiatry, 3(2), 151–160. https://doi.org/10.1007/s40501-016-0076-7
March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., Burns, B., Domino, M., McNulty, S.,
Vitiello, B., Severe, J., & Treatment for Adolescents With Depression Study (TADS) Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA, 292(7), 807–820. https://doi.org/10.1001/jama.292.7.807
Patel, D. R., Feucht, C., Brown, K., & Ramsay, J. (2018). Pharmacological treatment of anxiety
disorders in children and adolescents: A review for practitioners. Translational Pediatrics, 7(1), 23–35. https://doi.org/10.21037/tp.2017.08.05
Walter, H. J., Bukstein, O. G., Abright, A. R., Keable, H., Ramtekkar, U., Ripperger-Suhler, J., &
Rockhill, C. (2020). Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2020.05.005
